Summary Box: FDA cuts Ambien dose over safety risk

Published



WAKEUP CALL: The Food and Drug Administration ordered makers of Ambien and related drugs to cut their dose in half to prevent morning sluggishness caused by the popular insomnia treatment.

DRIVING ACCIDENTS: The agency said it has received reports of driving accidents caused by the drugs for years. But recently one drugmaker performed the first studies measuring patients’ driving ability while taking various drug doses.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.